Cost Effectiveness Analysis of Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) for Early Stage Renal Cell Carcinoma (RCC)
E. Donovan, Feng Xie, Alexander V. Louie, William Chu, Shankar Siva, Anil Kapoor, Anand Swaminath
Topics & Concepts
MedicineRadiofrequency ablationRenal cell carcinomaCost-effectiveness analysisStage (stratigraphy)CohortRadiologyCost effectivenessAblationOncologyInternal medicineBiologyRisk analysis (engineering)PaleontologyRenal cell carcinoma treatmentHepatocellular Carcinoma Treatment and PrognosisBladder and Urothelial Cancer Treatments